Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Issuance of Common Stock

Alexion Pharm Inc Issuance of Common Stock Chart (ALXN)

Alexion Pharm Inc annual/quarterly Issuance of Common Stock from 2010 to 2020.
  • Alexion Pharm Inc Issuance of Common Stock for the quarter ending September 09, 2020 was $9m a 27.17% increase of 3m year over year
  • Alexion Pharm Inc Issuance of Common Stock for the last 12 months ending September 09, 2020 was $29m a -3.82% decrease of -1m year over year
  • Alexion Pharm Inc Annual Issuance of Common Stock for 2019 was $30m a -58.19% decrease of -17m from 2018
  • Alexion Pharm Inc Annual Issuance of Common Stock for 2018 was $47m a -81.61% decrease of -39m from 2017
  • Alexion Pharm Inc Annual Issuance of Common Stock for 2017 was $86m a 56.81% increase of 49m from 2016
Other Cash Flow Metrics:
  • Alexion Pharm Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $387m a 33.45% increase of 130m year over year
  • Alexion Pharm Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $227m a 35.57% increase of 81m year over year
  • Alexion Pharm Inc Total Revenue for the quarter ending December 12, 2018 was $1,129m a 17.53% increase of 198m year over year
View Chart On Koyfin

Quarterly ALXN Issuance of Common Stock Data

09/2020$9m
06/2020$10m
03/2020$3m
12/2019$7m
09/2019$3m
06/2019$10m
03/2019$10m
12/2018$6m
09/2018$17m
06/2018$15m

Annual ALXN Issuance of Common Stock Data

2019$30m
2018$47m
2017$86m
2016$37m
2015$82m
2014$114m
2013$71m
2012$529m
2011$36m
2010$38m